Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 12/20 | 0.55 |
| ▸ | PIK3CG | P48736 | 12/20 | 0.55 |
| ▸ | PIK3CD | O00329 | 11/20 | 0.55 |
| ▸ | PIK3CB | P42338 | 11/20 | 0.55 |
| ▸ | PRKDC | P78527 | 11/20 | 0.55 |
| ▸ | ABL1 | P00519 | 11/20 | 0.55 |
| ▸ | SRC | P12931 | 11/20 | 0.55 |
| ▸ | EGFR | P00533 | 10/20 | 0.55 |
| ▸ | HCK | P08631 | 10/20 | 0.55 |
| ▸ | MTOR | P42345 | 10/20 | 0.55 |
| ▸ | EPHB4 | P54760 | 10/20 | 0.55 |
| ▸ | KDR | P35968 | 9/20 | 0.55 |
| ▸ | PI4KB | Q9UBF8 | 4/20 | 0.54 |
| ▸ | RIPK1 | Q13546 | 6/20 | 0.51 |
| ▸ | NUDT14 | O95848 | 1/20 | 0.48 |
| ▸ | NUDT5 | Q9UKK9 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13828435 | 0.88 | PIK3CD (0.54) | PIK3CAPIK3CGPIK3CDPIK3CBPRKDC | |
| SCHEMBL22275887 | 0.84 | NUDT14 (0.57) | PIK3CAPIK3CGPIK3CDPIK3CBPRKDC | |
| SCHEMBL130477 | 0.81 | ADK (0.55) | PIK3CAPIK3CGPIK3CDPIK3CBPRKDC | |
| SCHEMBL30320627 | 0.81 | PIK3CD (0.65) | PIK3CAPIK3CGPIK3CDPIK3CBPRKDC | |
| SCHEMBL21436859 | 0.81 | PIK3CD (0.65) | PIK3CAPIK3CGPIK3CDPIK3CBPRKDC | |
| SCHEMBL13718043 | 0.78 | MAPT (0.47) | — | |
| SCHEMBL130598 | 0.77 | SRC (0.75) | PIK3CAPIK3CGPIK3CDPIK3CBPRKDC | |
| SCHEMBL130500 | 0.76 | PIK3CA (0.76) | PIK3CAPIK3CGPIK3CDPIK3CBPRKDC | |
| SCHEMBL129582 | 0.75 | PIK3CD (0.73) | PIK3CAPIK3CGPIK3CDPIK3CBPRKDC | |
| SCHEMBL13019672 | 0.75 | SRC (0.69) | PIK3CAPIK3CGPIK3CDPIK3CBPRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10322130-B2 | Substituted chromenones as modulators of protein kinases | RHIZEN PHARMACEUTICALS SA (CH) | 2019-06-18 | — | — | US | disclosed |
| US-20190105324-A9 | SUBSTITUTED CHROMENONES AS MODULATORS OF PROTEIN KINASES | RHIZEN PHARMACEUTICALS AG (CH) | 2019-04-11 | — | — | US | disclosed |
| US-10220035-B2 | Compounds as modulators of protein kinases | RHIZEN PHARMACEUTICALS SA (CH) | 2019-03-05 | — | — | US | disclosed |
| US-20180110783-A1 | NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES | RHIZEN PHARMACEUTICALS SA (CH) | 2018-04-26 | — | — | US | disclosed |
| US-20180110783-A1 | NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES | RHIZEN PHARMACEUTICALS SA (CH) | 2018-04-26 | — | — | US | disclosed |
| US-9775841-B2 | Compounds as modulators of protein kinases | RHIZEN PHARMACEUTICALS SA (CH) | 2017-10-03 | — | — | US | disclosed |
| US-20150320752-A1 | NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES | RHIZEN PHARMACEUTICALS AG (CH) | 2015-11-12 | — | — | US | disclosed |
| US-20120289496-A1 | NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES | RHIZEN PHARMACEUTICALS SA (CH) | 2012-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150320752-A1 | NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES | PRKCA, PRKCH, PRKCB | PIK3CA 88/4885PIK3CG 77/4885PIK3CD 47/4885 |
| US-20120289496-A1 | NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES | PRKCA, PRKCH, PRKCB | PIK3CA 88/4885PIK3CG 77/4885PIK3CD 47/4885 |
| US-20190105324-A9 | SUBSTITUTED CHROMENONES AS MODULATORS OF PROTEIN KINASES | PRKCA, PRKCH, PRKAR2B | PIK3CA 106/4885PIK3CG 128/4885PIK3CD 89/4885 |
| US-10220035-B2 | Compounds as modulators of protein kinases | PRKCA, PRKCH, PRKCE | PIK3CA 64/4885PIK3CG 60/4885PIK3CD 30/4885 |
| US-20180110783-A1 | NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES | PRKCA, PRKCH, PRKCB | PIK3CA 88/4885PIK3CG 77/4885PIK3CD 47/4885 |
| US-10322130-B2 | Substituted chromenones as modulators of protein kinases | MAP3K1, CSNK1A1, MAP3K2 | PIK3CA 153/4885PIK3CG 194/4885PIK3CD 148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.